Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry

Open access
Adisasmito, Wiku, Chan, Paul K. S, Lee, Nelson, Oner, Ahmet Faik, Gasimov, Viktor, Aghayev, Faik, Zaman, Mukhtiar, Bamgboye, Ebun, Dogan, Nazim, Coker, Richard, Starzyk, Kathryn, Dreyer, Nancy A., Toovey, Stephen·2010·The Journal of Infectious Diseases

Abstract

Background. Influenza A(H5N1) continues to cause infections and possesses pandemic potential. Methods. Data sources were primarily clinical records, published case series, and governmental agency reports. Cox proportional hazards regression was used to estimate the effect of treatment on survival, with adjustment using propensity scores (a composite measure of baseline variables predicting use of treatment). Results. In total, 308 cases were identified from 12 countries: 41 from Azerbaijan, Hong Kong SAR, Nigeria, Pakistan, and Turkey (from clinical records); 175 from Egypt and Indonesia (from various sources); and 92 from Bangladesh, Cambodia, China, Thailand, and Vietnam (from various publications). Overall crude survival was 43.5%; 60% of patients who received ⩾1 dose of oseltamivir alone (OS+) survived versus 24% of patients who had no evidence of anti-influenza antiviral treatment (OS−) ( P < .001). Survival rates of OS+ groups were significantly higher than those of OS− groups; benefit persisted with oseltamivir treatment initiation ⩽6–8 days after symptom onset. Multivariate modeling showed 49% mortality reduction from oseltamivir treatment. Conclusions. H5N1 causes high mortality, especially when untreated. Oseltamivir significantly reducesmortality when started up to 6–8 days after symptom onset and appears to benefit all age groups. Prompt diagnosis and early therapeutic intervention should be considered for H5N1 disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/656316

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
Adisasmito, W., Chan, P. K. S., Lee, N., Oner, A. F., Gasimov, V., Aghayev, F., Zaman, M., Bamgboye, E., Dogan, N., Coker, R., Starzyk, K., Dreyer, N. A., & Toovey, S.
Venue
The Journal of Infectious Diseases
Published
2010-10-15
Volume
202
Issue
8
Pages
1154-1160
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2107569667
Cited by
161
References
1
FWCI
10.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry. https://app.cochat.ai/papers/10.1086/656316
The paper
Adisasmito, W., Chan, P. K. S., Lee, N., Oner, A. F., Gasimov, V., Aghayev, F., Zaman, M., Bamgboye, E., Dogan, N., Coker, R., Starzyk, K., Dreyer, N. A., & Toovey, S. (2010). Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry. The Journal of Infectious Diseases. https://doi.org/10.1086/656316

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.